Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CVS HEALTH CorpCVS · Entity 2884 | EVP | January 02, 2015 | January 05, 2015 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CVS HEALTH Corp
Report date January 02, 2015 · Filed January 05, 2015
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 23,419 |
Ending reported balance
After 2015-01-02 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2015-01-02 · Exercise / conversion · Acquired 347,343 · Balance 370,762 Row 2 · 2015-01-02 · Sale · Disposed 347,343 · Balance 23,419 F1: All sales were effected pursuant to a Rule 10b5-1 plan. F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.40 and $96.86 per share. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $45.07 · Expires 2019-04-02 | Direct | 0 |
Reported balance
After 2015-01-02 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2015-01-02 · Exercise / conversion · Disposed 347,343 · Balance 0 F3: Option became exercisable on December 31, 2013. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $70.40 · Expires 2021-01-02 | Direct | 112,181 |
Reported balance
Holding disclosure · report date 2015-01-02 · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · Balance 112,181 F4: Option became exercisable on December 31, 2014. |
| Stock OptionSEC Table II · derivative / convertible security · Conversion / exercise price $91.36 · Expires 2021-11-28 | Direct | 138,477 |
Reported balance
Holding disclosure · report date 2015-01-02 · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · Balance 138,477 F5: Option becomes exercisable on December 31, 2015. |
| Common StockSEC Table I · non-derivative | IndirectBy Lofberg Family Partnership, L.P. | 162,000 |
Reported balance
Holding disclosure · report date 2015-01-02 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 162,000 |
| Common StockSEC Table I · non-derivative | IndirectBy Trusts | 14,400 |
Reported balance
Holding disclosure · report date 2015-01-02 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 14,400 |
| Stock UnitSEC Table I · non-derivative | Direct | 223,118.6432 |
Reported balance
Holding disclosure · report date 2015-01-02 · row 5
Holding and transaction disclosures are not merged.
1 source rowRow 5 · Balance 223,118.6432 |
Filing footnotes · ownership attribution and instrument terms
F1: All sales were effected pursuant to a Rule 10b5-1 plan.
F2: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.40 and $96.86 per share.
F3: Option became exercisable on December 31, 2013.
F4: Option became exercisable on December 31, 2014.
F5: Option becomes exercisable on December 31, 2015.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2015 Filed Jan 5, 2015 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 347,343 | $0.00 Strike: $45.07 | $0.00 |
DisclosureSEC source: 0001127602-15-000743 · form4.xml · derivative · entry 6 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 347,343 shares Expires 2019-04-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Option became exercisable on December 31, 2013. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 347,343 | $95.28 | $33,096,438.82 |
DisclosureSEC source: 0001127602-15-000743 · form4.xml · nonDerivative · entry 2 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,419 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $94.40 and $96.86 per share. Read SEC document |
| January 02, 2015 Filed Jan 5, 2015 21:52 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 347,343 | $45.07 | $15,654,749.01 |
DisclosureSEC source: 0001127602-15-000743 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 370,762 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2014 Filed Dec 2, 2014 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 138,477 | $91.36 Strike: $91.36 | $12,651,258.72 |
DisclosureSEC source: 0001127602-14-033860 · form4.xml · derivative · entry 5 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 138,477 Underlying: Common Stock · 138,477 shares Expires 2021-11-28 F1 · derivative.exercise_date: Option becomes exercisable on December 31, 2015. Read SEC document |
| November 06, 2014 Filed Dec 2, 2014 21:15 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 22,981 | $88.43 | $2,032,209.83 |
DisclosureSEC source: 0001127602-14-033860 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,419 Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 53,124 | $0.00 Strike: $32.98 | $0.00 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · derivative · entry 16 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,124 shares Expires 2020-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable on 12/31/2012. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 101,992 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · derivative · entry 15 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 101,992 shares Expires 2017-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F9 · derivative.exercise_date: The Option becomes exercisable in three equal installments on April 1, 2011, April 1, 2012 and April 1, 2013, provided, however, that if the reporting person remains employed through December 31, 2012, then the option shall become exercisable in full as of December 31, 2012, and shall remain exercisable for one year following the reporting person's last date of employment with the Company. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 234,066 | $0.00 Strike: $34.96 | $0.00 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · derivative · entry 14 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 234,066 shares Expires 2018-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: Option became exercisable on 12/31/2012. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 53,124 | $70.61 | $3,751,085.64 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 8 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,400 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F5 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.43 and $70.75 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 53,124 | $32.98 | $1,752,029.52 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 7 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 101,992 | $70.47 | $7,187,376.24 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 6 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,400 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F4 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.71 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 101,992 | $36.23 | $3,695,170.16 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 5 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 148,392 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 234,066 | $70.47 | $16,494,631.02 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 4 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,400 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F3 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.26 and $70.71 per share. Read SEC document |
| January 03, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 234,066 | $34.96 | $8,182,947.36 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 3 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 280,466 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 112,181 | $70.40 Strike: $70.40 | $7,897,542.40 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · derivative · entry 13 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,181 Underlying: Common Stock · 112,181 shares Expires 2021-01-02 F7 · derivative.exercise_date: Option becomes exercisable on December 31, 2014. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 401,706 | $0.00 Strike: $32.98 | $0.00 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · derivative · entry 12 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,124 Underlying: Common Stock · 401,706 shares Expires 2020-01-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Option became exercisable on 12/31/2012. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 401,706 | $70.58 | $28,352,409.48 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 2 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,400 F1 · kind: All sales were effected pursuant to a Rule 10b5-1 plan. F2 · price: Represents weighted average sale price for this trading day. Multiple sales were executed, with sales prices ranging between $70.19 and $70.97 per share. Read SEC document |
| January 02, 2014 Filed Jan 3, 2014 23:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 401,706 | $32.98 | $13,248,263.88 |
DisclosureSEC source: 0001127602-14-001013 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,106 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 19, 2013 Filed Feb 21, 2013 21:59 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 28,484 | $52.66 | $1,499,967.44 |
DisclosureSEC source: 0001127602-13-007333 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 217,454.4303 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| April 02, 2012 Filed Apr 4, 2012 20:51 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 347,343 | $45.07 Strike: $45.07 | $15,654,749.01 |
DisclosureSEC source: 0001127602-12-013322 · form4.xml · derivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 347,343 Underlying: Common Stock · 347,343 shares Expires 2019-12-31 F1 · derivative.exercise_date: Option becomes exercisable on December 31, 2013. Read SEC document |
| February 13, 2012 Filed Feb 15, 2012 20:48 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 46,400 | $42.99 | $1,994,736.00 |
DisclosureSEC source: 0001127602-12-006134 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 69,798.4631 F1 · price: Represents weighted average purchase for this trading day. Multiple purchases were executed, with purchase prices ranging between $42.98 and $43.02 per share. Read SEC document |
| February 07, 2012 Filed Feb 9, 2012 21:58 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 65,250 | $43.08 | $2,810,970.00 |
DisclosureSEC source: 0001127602-12-004941 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,044.8686 F1 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 2010 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| April 01, 2011 Filed Apr 5, 2011 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 234,066 | $34.96 Strike: $34.96 | $8,182,947.36 |
DisclosureSEC source: 0001127602-11-012402 · form4.xml · derivative · entry 1 Lofberg Per GH · CIK 0001318289 · EVP and President, Caremark 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 234,066 Underlying: Common Stock · 234,066 shares Expires 2018-04-01 F1 · derivative.exercise_date: Option becomes exercisable on 12/31/2012. Read SEC document |
| August 17, 2010 Filed Aug 18, 2010 20:10 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 4,000 | $29.08 | $116,318.00 |
DisclosureSEC source: 0001127602-10-021635 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Indirect · By Lofberg Family Partnership, L.P. Disclosed balance after: 162,000 Read SEC document |
| August 11, 2010 Filed Aug 12, 2010 20:02 UTC | CVS HEALTH Corp CVS · Entity 2884 | GiftCommon Stock | 14,400 | $29.31 | $422,064.00 |
DisclosureSEC source: 0001127602-10-021230 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Indirect · By Trusts Disclosed balance after: 14,400 F1 · shares: These shares are held in separate trusts established for the benefit of the reporting person's children. The reporting person is not a trustee of the childrens' trusts and disclaims any beneficial ownership of these securities. The filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. F2 · price: Represents weighted average purchase for this trading day. Multiple purchases were executed, with purchase prices ranging between $29.2787 and $29.3327. Read SEC document |
| August 09, 2010 Filed Aug 11, 2010 20:00 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 11,000 | $29.86 | $328,460.00 |
DisclosureSEC source: 0001127602-10-021142 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Indirect · By Lofberg Family Partnership, L.P. Disclosed balance after: 158,000 Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 101,992 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-010580 · form4.xml · derivative · entry 5 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,992 Underlying: Common Stock · 101,992 shares Expires 2017-04-01 F2 · shares: Option become exercisable in three equal annual installments commencing 4/1/2011 and the third installment becomes excisable on 12/31/2012. Read SEC document |
| April 01, 2010 Filed Apr 5, 2010 22:49 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 27,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-010580 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,602 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse on two equal installments 50% on 12/31/2012 and 50% on 4/1/2013. Read SEC document |
| April 01, 2010 Filed Aug 10, 2010 16:59 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 101,992 | $0.00 Strike: $36.23 | $0.00 |
DisclosureSEC source: 0001127602-10-021023 · form4a.xml · derivative · entry 2 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,992 Underlying: Common Stock · 101,992 shares Expires 2017-04-01 F2 · derivative.exercise_date: The Option become exercisable in three equal installments on April 1, 2011, April 1, 2012 and April 1, 2013, provided, however, that if the reporting person remains employed through December 31, 2012, then the option shall become exercisable in full as of December 31, 2012, and shall remain exercisable for one year following the reporting person's last date of employment with the Company. Read SEC document |
| April 01, 2010 Filed Aug 10, 2010 16:59 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (restricted) | 27,602 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-10-021023 · form4a.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,602 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's 1997 Incentive Compensation Plan. Restrictions lapse on the third anniversary of the grant date, provided that if the reporting person remains employed by the Company through December 31, 2012, the restrictions lapse on December 31, 2012. Read SEC document |
| February 17, 2010 Filed Feb 19, 2010 20:45 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 147,000 | $34.10 | $5,012,582.40 |
DisclosureSEC source: 0001127602-10-005613 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Indirect · By Lofberg Family Partnership, L.P. Disclosed balance after: 147,000 F1 · price: Represents weighted average purchase price for this trading day. Multiple purchases were executed, with purchase prices ranging between $34.08 to $34.10. Read SEC document |
| January 04, 2010 Filed Jan 6, 2010 21:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 454,830 | $0.00 Strike: $32.98 | $0.00 |
DisclosureSEC source: 0001127602-10-000959 · form4.xml · derivative · entry 3 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,830 Underlying: Common Stock · 454,830 shares Expires 2020-01-04 F2 · derivative.exercise_date: Option becomes exercisable on 1/4/2013. Read SEC document |
| January 04, 2010 Filed Jan 6, 2010 21:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (pep) | 45,483 | $32.98 | $1,500,029.34 |
DisclosureSEC source: 0001127602-10-000959 · form4.xml · nonDerivative · entry 2 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,483 F1 · shares: Consists of Restricted Stock Units awarded pursuant to Issuer's Partnership Equity Program under the 1997 Incentive Compensation Plan. Restrictions lapse 50% on 1/4/2012 and 50% on 12/31/2012. Read SEC document |
| January 04, 2010 Filed Jan 6, 2010 21:27 UTC | CVS HEALTH Corp CVS · Entity 2884 | PurchaseCommon Stock | 45,483 | $32.98 | $1,500,029.34 |
DisclosureSEC source: 0001127602-10-000959 · form4.xml · nonDerivative · entry 1 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,483 Read SEC document |
| January 04, 2010 Filed Feb 9, 2011 20:36 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 454,830 | $0.00 Strike: $32.98 | $0.00 |
DisclosureSEC source: 0001127602-11-004605 · form4a.xml · derivative · entry 1 Lofberg Per GH · CIK 0001318289 · President, Caremark Pharm Serv 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 454,830 Underlying: Common Stock · 454,830 shares Expires 2020-01-03 F1 · derivative.exercise_date: The purpose of this Amended Form 4A is to correct the vesting schedule and expiration date due to a clerical error. The Stock Option becomes exercisable on 12/31/2012 and expires on 1/3/2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.